The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting

about

The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting

Item

http://www.wikidata.org/entity/Q36185925

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The risk of biopsy-detectable ...... culator in a community setting

@ast

The risk of biopsy-detectable ...... culator in a community setting

@en

type

Item

label

The risk of biopsy-detectable ...... culator in a community setting

@ast

The risk of biopsy-detectable ...... culator in a community setting

@en

prefLabel

The risk of biopsy-detectable ...... culator in a community setting

@ast

The risk of biopsy-detectable ...... culator in a community setting

@en

P1476

The risk of biopsy-detectable ...... culator in a community setting

@en

P2093

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

Janet L Stanford

http://www.w3.org/2001/XMLSchema#string

Rong Fu

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Liang

http://www.w3.org/2001/XMLSchema#string

Ziding Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

American Cancer Society guideline for the early detection of prostate cancer: update 2010

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group

Screening and prostate-cancer mortality in a randomized European study

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

Prediction models in cancer care.

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.

Prostate cancer risk prediction in a urology clinic in Mexico.

P304

1464-1469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2012.03.012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Donna Ankerst

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22552047

http://www.w3.org/2001/XMLSchema#string

P932

3426631

http://www.w3.org/2001/XMLSchema#string